Genetic testing for relevant genes such as PALB2 must be included in molecular and genetic evaluation of breast cancer patient from this population, which could contribute, to a better understanding of breast cancer risk and implementing preventive and therapeutic strategies for breast cancer patients from Middle Eastern ethnicity. Here, PALB2 is linked to breast carcinoma.